Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two one-day drug license suspension orders from drug regulatory authorities. One order from the Assistant Director, Drugs Control Administration in Nizamabad, Telangana suspends the license for a store at Metpally Road Armoor, effective from the order received on 08.05.2026. The second order from the Bidar Circle authority in Karnataka suspends a store license at Shivnagar Bidar. Both suspensions are for violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. The company estimates a combined potential revenue loss of Rs 0.24 lakhs from these suspensions.
The financial and operational impact is minimal with only one-day suspensions and a combined revenue exposure of Rs 24,000. This appears to be a routine regulatory compliance matter unlikely to materially affect the stock price.